Nimble Therapeutics - Ownership and Business Overview

Life ScienceCompany

Nimble Therapeutics Ownership

Who owns Nimble Therapeutics?

Nimble Therapeutics is owned by AbbVie. It was acquired on December 13, 2024.

Was Nimble Therapeutics formerly PE-backed?

Yes. Nimble Therapeutics was formerly owned by 1 private investor.

Nimble Therapeutics Business Overview

Where is Nimble Therapeutics headquartered?

Nimble Therapeutics is headquartered in Madison, Wisconsin.

What sector is Nimble Therapeutics in?

Nimble Therapeutics is a life science company.

When was Nimble Therapeutics founded?

Nimble Therapeutics was founded in 2019.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 203 acquisitions of life science companies in 2024, including 20 acquisitions by private equity firms, and 183 by strategics.

Nimble Therapeutics

Nimble Therapeutics, Inc.

603 Science Drive,
Madison, Wisconsin 53711
United States,
www.nimbletherapeutics.com

Nimble Therapeutics is a provider of massively parallel chemical synthesis to drug discovery. Nimble’s proprietary technology enables the synthesis and screening of millions of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Nimble Therapeutics was founded in 2019 and is based in Madison, Wisconsin.


 Subscribe to unlock this and 208,934
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.